IDEXX Labs (IDXX) Tops Q2 EPS by 34c, updates guidance

IDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $3.63, $0.34 better than the analyst estimate of $3.29. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.06 billion.

GUIDANCE:

IDEXX Labs sees FY2025 EPS of $12.40-$12.76, versus the consensus of $12.21. IDEXX Labs sees FY2025 revenue of $4.205-4.28 billion, versus the consensus of $4.149 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Myriad Uranium completes acquisition of Rush Rare Metals
• Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders